https://www.selleckchem.com/products/ca77-1.html
889; 95% CI, 1.401-5.959; = 0.004; overall survival (OS) HR, 2.655; 95% CI, 1.218-5.787; = 0.014] was the best predictor of poor prognosis. SMG, SMD, SMI and LBM were identified as predictors of adverse reactions and poor survival. SMG was an innovative and valuable indicator of immunochemotherapy toxicity and other adverse outcomes. Additionally, it can be used to individualize antineoplastic drug dosing. SMG, SMD, SMI and LBM were identified as predictors of adverse reactions and poor survival. SMG was an innovative and valuable indica